Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies.

Autor: Paranjpe MG; 1 BioReliance By SAFC, Rockville, MD, USA., Belich J; 1 BioReliance By SAFC, Rockville, MD, USA., Vidmar TJ; 2 BioSTAT Consultants, Inc., Portage, MI, USA., Elbekai RH; 3 PAREXEL International, Bethesda, MD, USA., McKeon M; 1 BioReliance By SAFC, Rockville, MD, USA., Brown C; 1 BioReliance By SAFC, Rockville, MD, USA.
Jazyk: angličtina
Zdroj: International journal of toxicology [Int J Toxicol] 2017 Jul/Aug; Vol. 36 (4), pp. 287-292. Date of Electronic Publication: 2017 May 28.
DOI: 10.1177/1091581817707458
Abstrakt: Our recent retrospective analysis of data, collected from 29 Tg.rasH2 mouse carcinogenicity studies, determined how successful the strategy of choosing the high dose for the 26-week studies was based on the estimated maximum tolerated dose (EMTD) derived from earlier 28-day dose range finding (DRF) studies conducted in CByB6F1 mice. Our analysis demonstrated that the high doses applied at EMTD in the 26-week Tg.rasH2 studies failed to detect carcinogenic effects. To investigate why the dose selection process failed in the 26-week carcinogenicity studies, the initial body weights, terminal body weights, body weight gains, food consumption, and mortality from the first 4 weeks of 26-week studies with Tg.rasH2 mice were compared with 28-day DRF studies conducted with CByB6F1 mice. Both the 26-week and the earlier respective 28-day studies were conducted with the exact same vehicle, test article, and similar dose levels. The analysis of our results further emphasizes that the EMTD and subsequent lower doses, determined on the basis of the 28-day studies in CByB6F1 mice, may not be an accurate strategy for selecting appropriate dose levels for the 26-week carcinogenicity studies in Tg.rasH2 mice. Based on the analysis presented in this article, we propose that the Tg.rasH2 mice and not the CByB6F1 mice should be used in future DRF studies. The Tg.rasH2 mice demonstrate more toxicity than the CByB6F1 mice, possibly because of their smaller size compared to CByB6F1 mice. Also, the Tg.rasH2 males appear to be more sensitive than the female Tg.rasH2 mice.
Databáze: MEDLINE